These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2287298)

  • 1. [Activity of cefoperazone and cefoperazone-sulbactam against gram-positive and gram-negative bacteria].
    Baykal M; Hasçelik G
    Mikrobiyol Bul; 1990 Oct; 24(4):383-5. PubMed ID: 2287298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of cefoperazone-sulbactam: Singapore experience.
    Kumarasinghe G; Chow C; Chiu C; Cheong YM
    Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):734-7. PubMed ID: 9253876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro activity of cefoperazone-sulbactam combination against cefoperazone resistant clinical isolates in a Malaysian general hospital.
    Lim VK; Cheong YM
    Malays J Pathol; 1995 Dec; 17(2):73-6. PubMed ID: 8935129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity against clinically important gram-positive and gram-negative bacteria of sulbactam, alone and in combination with ampicillin, cefotaxime, mezlocillin, and piperacillin.
    Schmalreck AF; Wildfeuer A
    Arzneimittelforschung; 1990 Oct; 40(10):1145-55. PubMed ID: 2291754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria.
    Wang FD; Lin ML; Lee WS; Liu CY
    Int J Antimicrob Agents; 2004 Jun; 23(6):590-5. PubMed ID: 15194130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of cefoperazone-sulbactam combination against gram negative bacilli.
    Poudyal N; Gyawali N; Gurung R; Bhattarai NR; Baral R; Khanal B; Shrestha S; Amatya R; Bhattacharya SK
    Nepal Med Coll J; 2012 Mar; 14(1):5-8. PubMed ID: 23441486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro susceptibility to cefoperazone and sulbactam/cefoperazone combination of bacterial strains isolated from various patient materials].
    Aksoy AM; Ozsan M; Ural O; Ekmen H
    Mikrobiyol Bul; 1993 Jul; 27(3):216-20. PubMed ID: 8361410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS; Tosin I; Sejas L; Miranda E
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro activity of aztreonam, cefoperazone and ceftriaxone against gram-negative bacteria].
    Baykal M; Hasçelik G
    Mikrobiyol Bul; 1990 Jul; 24(3):248-50. PubMed ID: 2283976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro antibacterial activity of sulperazone on multi-resistant strains of bacteria from burn wounds].
    Xu W; Chen X
    Zhonghua Wai Ke Za Zhi; 1995 Jul; 33(7):390-2. PubMed ID: 8565723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of cefoperazone plus sulbactam compared with that of other antimicrobial agents against anaerobic bacteria.
    Wexler HM; Finegold SM
    Antimicrob Agents Chemother; 1988 Mar; 32(3):403-6. PubMed ID: 3364960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulbactam-containing beta-lactamase inhibitor combinations.
    Akova M
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():185-8. PubMed ID: 18154545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vitro activity of cefoperazone and various combinations of cefoperazone/sulbactam.
    Knapp CC; Sierra-Madero J; Washington JA
    Diagn Microbiol Infect Dis; 1990; 13(1):45-9. PubMed ID: 2331849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Criteria for disk susceptibility tests and quality control guidelines for the cefoperazone-sulbactam combination.
    Barry AL; Jones RN
    J Clin Microbiol; 1988 Jan; 26(1):13-7. PubMed ID: 3343304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative in vitro activity ampicillin, cefoperazone, their combinations with sulbactam, as well as that of other antibiotics against aerobic gram-negative microorganisms].
    Sidorenko SV; Rezvan SP; Speranskaia ON; Krotova LA; Tikhonova AS; Strachunskiĭ LS; Navashin SM; Kuleshov SE; Budanov SV; Ansolis LE
    Antibiot Khimioter; 1994 Nov; 39(11):10-20. PubMed ID: 7733770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Distribution and drug-resistance of 3 500 gram-negative bacteria in Guangzhou].
    Xiao QZ; Su DH; Jiang JH; Zhong NS
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):132-8. PubMed ID: 15698988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility tests with cefoperazone compared with cefotaxime, cefoxitin, cefuroxime, cephaloridine and gentamicin.
    Brenciaglia MI; Cipriani P; Ghezzi MC; Giordano A; Mancini C; Rivanera D; Filadoro F
    Chemioterapia; 1984 Aug; 3(4):246-9. PubMed ID: 6099754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefoperazone/sulbactam: New composites against multiresistant gram negative bacteria?
    Ku YH; Yu WL
    Infect Genet Evol; 2021 Mar; 88():104707. PubMed ID: 33418147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro activity of ampicillin and ampicillin-sulbactam on diverse bacteria].
    Trucco O; Prado V; Mollinedo E; Cordoves A
    Rev Med Chil; 1989 Jul; 117(7):747-54. PubMed ID: 2519428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical experience with the treatment of severe nosocomial infections by inhibitor-protected 3rd generation cephalosporin cefoperazone/sulbactam].
    Beloborodova NV; Kuznetsova ST; Popov DA; Bachinskaia EN; Vostrikov TIu
    Antibiot Khimioter; 2005; 50(4):33-40. PubMed ID: 16392338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.